Therefore, utilizing CHC to inhibit MCT1 mediated lactate influx can efficiently relieve the hypoxia condition of tumor cells, which consequently promoted the catalytical activity of GOx, leading to further glucose depletion and toxic H2O2 production (Scheme 1). The gene discussed is HAO1; the disease is neoplasm.